SCHEMBL8084237

SCHEMBL8084237

Oc1cccc(CCNCCCCCc2ccccc2)c1

nearest known ligand 0.74

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 8/20 0.72
ADRB2 P07550 1/20 0.66
ADORA3 P0DMS8 1/20 0.66
CHRM1 P11229 1/20 0.66
ADRA2B P18089 1/20 0.66
ADRA2C P18825 1/20 0.66
DRD1 P21728 1/20 0.66
SLC6A2 P23975 1/20 0.66
SLC6A4 P31645 1/20 0.66
ADRA1A P35348 1/20 0.66
PTGS2 P35354 1/20 0.66
HRH1 P35367 1/20 0.66
DRD3 P35462 1/20 0.66
OPRK1 P41145 1/20 0.66
SLC6A3 Q01959 1/20 0.66
PDE4D Q08499 1/20 0.66
KCNH2 Q12809 1/20 0.66
HRH3 Q9Y5N1 1/20 0.66
SLC6A5 Q9Y345 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18114812 0.90 OPRK1 (0.62) SIGMAR1ADRB2ADORA3CHRM1ADRA2B
SCHEMBL5542136 0.87 OPRK1 (0.67) DRD1DRD3OPRK1
SCHEMBL28352345 0.87 OPRK1 (0.67) DRD1DRD3OPRK1
SCHEMBL5537554 0.87 OPRK1 (0.67) DRD1DRD3OPRK1
SCHEMBL7435948 0.86 OPRK1 (0.64) SIGMAR1ADRB2ADORA3CHRM1ADRA2B
SCHEMBL7283717 0.85 ADRB2 (0.56) SIGMAR1ADRB2ADORA3CHRM1ADRA2B
SCHEMBL5544469 0.85 OPRK1 (0.69) CHRM1DRD1DRD3OPRK1
SCHEMBL8091327 0.85 SIGMAR1 (1.00) SIGMAR1
SCHEMBL7369457 0.85 SIGMAR1 (1.00) SIGMAR1
SCHEMBL7379499 0.83 SIGMAR1 (0.79) SIGMAR1ADRB2ADORA3CHRM1ADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6057371-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION VIRGINIA COMMONWEALTH UNIVERSITY (US) 2000-05-02 US claimed
EP-0591426-A1 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1994-04-13 EP claimed
WO-1993000313-A2 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1993-01-07 WO claimed
US-6057371-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION VIRGINIA COMMONWEALTH UNIVERSITY (US) 2000-05-02 US disclosed
EP-0591426-A1 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1994-04-13 EP disclosed
WO-1993000313-A2 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1993-01-07 WO disclosed